Sundial Growers Interest Expense 2011-2026 | SNDL

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Sundial Growers

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	81 K	178 K	40 K	7.77 M	14.4 M	2.92 M	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
14.4 M	40 K	4.23 M

Interest Expense of other stocks in the Drug manufacturers industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	1.12 M	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	4.92 K	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	1.42 M	-	10.11 %	$ 58.2 M	USA
Aerie Pharmaceuticals AERI	-27.9 M	-	-	$ 754 M	USA
Alimera Sciences ALIM	10.2 M	-	-	$ 142 M	USA
Canopy Growth Corporation CGC	74.6 M	$ 1.14	-4.62 %	$ 123 M	Canada
Cumberland Pharmaceuticals CPIX	606 K	$ 4.74	1.94 %	$ 66.6 M	USA
Catalent CTLT	-4 M	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	4.04 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	350 M	-	-	$ 28.9 M	Irlanda
HEXO Corp. HEXO	20.1 M	-	2.45 %	$ 38.1 M	Canada
Evoke Pharma EVOK	500 K	-	-	$ 36.6 M	USA
DURECT Corporation DRRX	2.24 M	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	87.9 M	$ 11.08	0.82 %	$ 567 M	USA
Athenex ATNX	25.8 M	-	-23.39 %	$ 1.76 M	USA
Evolus EOLS	127 K	$ 5.05	-2.88 %	$ 313 M	USA
Harrow Health HROW	21.3 M	$ 47.49	-0.86 %	$ 1.55 B	USA
China Pharma Holdings CPHI	27.4 K	$ 1.25	-	$ 21.8 M	China
Jupiter Wellness JUPW	-5.37 M	-	-	$ 33.6 M	USA
Bausch Health Companies BHC	-28 M	$ 6.75	-3.3 %	$ 2.46 B	Canada
Neoleukin Therapeutics NLTX	12 K	-	-	$ 193 M	Canada
Lannett Company LCI	58 M	-	1.15 %	$ 7.11 M	USA
Organogenesis Holdings ORGO	20 K	$ 3.64	-3.96 %	$ 479 M	USA
Pacira BioSciences PCRX	-373 K	$ 19.43	1.38 %	$ 899 M	USA
Avadel Pharmaceuticals plc AVDL	13 M	$ 21.51	0.14 %	$ 2.05 B	France
PetIQ PETQ	38.3 M	-	1.64 %	$ 400 M	USA
Perrigo Company plc PRGO	900 K	$ 15.06	0.2 %	$ 2.07 B	USA
ProPhase Labs PRPH	764 K	-	-	$ 5.07 M	USA
Recro Pharma REPH	9.96 M	-	-4.76 %	$ 65.3 M	USA
Rockwell Medical RMTI	2.3 M	$ 1.22	27.44 %	$ 28.5 M	USA
Radius Health RDUS	18.3 M	-	-	$ 1.42 B	USA
Sonoma Pharmaceuticals SNOA	-10 K	$ 3.33	1.06 %	$ 4.13 M	USA
Relmada Therapeutics RLMD	5.15 M	$ 3.93	5.01 %	$ 118 M	USA
OptiNose OPTN	19.5 M	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	2.78 M	$ 12.04	4.88 %	$ 855 M	USA
Tilray TLRY	46.6 M	$ 8.74	-7.62 %	$ 5.4 B	Canada
Solid Biosciences SLDB	652 K	$ 5.59	2.19 %	$ 228 M	USA
SCYNEXIS SCYX	3.13 M	$ 0.65	-0.68 %	$ 31.1 M	USA
Tricida TCDA	17.6 M	-	-	$ 3.25 M	USA
Veru VERU	862 K	$ 2.53	-5.95 %	$ 341 M	USA
TherapeuticsMD TXMD	300 K	$ 2.55	14.39 %	$ 26.6 M	USA
Viatris VTRS	592 M	$ 12.66	-1.59 %	$ 15.3 B	USA
Zomedica Corp. ZOM	175 K	-	-0.21 %	$ 98 M	USA
cbdMD YCBD	-29.5 K	$ 0.83	-9.94 %	$ 3.58 M	USA